Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Foulkes to quit Southern Cross
- Southern Cross Healthcare, the care homes group that last month raised £13.3m ($21.2m) from property and business disposals, is set to part company with its director of operations.Kamma Foulkes, who had been in the role since early 2007, was responsible for about half of the group's operations and was...
- External links 2009-10-05
- Tories plan to scrap national health database
- The Conservatives would scrap plans for a nationally available electronic patient record and halt, and then seek to renegotiate, the remainder of £5bn-worth of deals to provide the NHS record locally, Stephen O'Brien, the Conservative health spokesman, said on Monday.Publishing a review of the £12bn NHS IT programme which...
- External links 2009-08-10
- Cancer drug audit set for late start
- Eight months after promising to audit the demand for cancer and other drugs that the NHS declines to fund, pilot projects to achieve that have yet to be launched, the Department of Health said yesterday.The pilot schemes should finally begin "later this year", a spokesman said as the Rarer...
- External links 2009-08-13
- Dechra revamps its pet food range
- Dechra, the veterinary products company, is to revamp its range of healthy pet foods as it taps into the growing demand from owners seeking treatment for animals with human-like ailments such as obesity, arthritis and allergies.Ian Page, chief executive, said the Stoke-based company planned a series of new and...
- External links 2009-09-01
- Elan dealt a blow with Biogen ruling
- Elan, the Irish domiciled pharmaceuticals company, suffered a sharp setback in its recapitalisation plans when a US judge ruledon Thursday that a planned $1.5bn deal with Johnson & Johnson violated the terms of an existing partnership with Biogen Idec.Deborah Batts, a Manhattan federal court judge, ruled that Elan had...
- External links 2009-09-03
- Roche and Glaxo to test swine flu drugs
- Roche, the Swiss pharmaceutical group, is funding a study to test the efficacy of its flu drug Tamiflu in combination with rival GlaxoSmithKline's Relenza, in one of several initiatives to extend further the market for its blockbuster antiviral treatment.David Reddy, Roche's pandemic taskforce leader, saidon Monday his company was...
- External links 2009-09-07
- Branson to fund health push with loan facility
- Sir Richard Branson has secured an $80m loan facility to fund fresh deals in financial services and healthcare in exchange for pledging part of his stake in Virgin Media to Credit Suisse.The "cap and collar" agreement would hedge the billionaire entrepreneur's exposure on about 2.5 per cent of the...
- External links 2009-09-10
- Construction industry boosted by stimulus funds
- Public spending showed signs of making a much-needed impact on the beleaguered construction industry yesterday as government stimulus money helped drive up new orders in the sector.More than £3bn of new work was commissioned in July, an increase of 39 per cent on the previous month, as investment on...
- External links 2009-09-10
- Novartis chip to help ensure bitter pills are swallowed
- Patients who fail to pop pills on time could soon benefit from having a chip on their shoulder, under a ground-breaking electronic system being developed by Novartis, the Swiss pharmaceuticals group.The company is testing technology that inserts a tiny microchip into each pill swallowed and sends a reminder to...
- External links 2009-09-21
- Flu vaccine price war hits high street
- Asda, the supermarket chain, has launched a price war for the seasonal flu vaccine with plans to offer injections at £8 each, undercutting high street rivals and the price it offered in its own stores last year.The company portrayed the move as a way to ease pressure on "struggling...
- External links 2009-09-21
- Actavis launches challenge to Pfizer drug
- Actavis, the Iceland-based generic company, yesterday launched the most high profile commercial challenge in western Europe to Pfizer's best-selling and patentprotected medicine.The company said it had made a first shipment of 30m tablets into Spain of a cheaper variant of Lipitor, known generically as atorvastatin, which is widely prescribed...
- External links 2009-10-01
- NHS trusts told to prepare for restrictions on funding
- Flagship NHS hospitals have yet to face up to the reality of the looming squeeze on health spending, the foundation trust regulator warns today.Three-year plans produced by the NHS foundation trusts - the selfgoverning hospitals and mental health services that now serve about half the population - show that...
- External links 2009-08-09
- NHS treats more patients for less cost
- National Health Service productivity has finally risen, according to an analysis by the Audit Commission , but primary care trusts are still struggling to control demand for the health service and move care out of hospitals into the community where it can sometimes be provided more cheaply."The good news...
- External links 2009-11-11
- Legal rights for patients planned
- A legal right for patients to go to a private hospital or other provider if the NHS fails to treat them within 18 weeks will be introduced next year, Gordon Brown, the prime minister, will announce today. A similar right will operate from the same date - April 2010...
- External links 2009-11-09
- London's Maggie's Centre is a Stirling winner
- It seemed somehow destined that this year's Stirling Prize, British architecture's best-known award, would go to Richard Rogers' practice Rogers Stirk Harbour + Partners. Lord Rogers had two buildings on the shortlist of six and the award was presented in the former Billingsgate fish market, converted by his practice...
- External links 2009-10-18
- GSK faces Merck in vaccine price war
- GlaxoSmithKline plans to undercut its rival Merck in a battle for sales following US regulatory approval for its cervical cancer vaccine Cervarix.The UK-based pharmaceutical group said it would charge less than Gardasil, Merck's vaccine, which generates more than $1bn ( by Financial Times
- External links 2009-10-19
- Merck reveals doctors' speaker fees after calls for transparency
- Merck paid more than $3m in speaker fees to US doctors during the second quarter of this year, according to figures from the company that represent a step towards greater transparency in the commercial links of the New Jersey-based pharmaceutical group with prescribers.The company has provided less information, however,...
- External links 2009-10-20
- Elan pins hopes on multiple sclerosis drug
- Kelly Martin, chief executive of Elan, said the Irish drugs group would focus on increasing sales of its multiple sclerosis drug Tysabri, following the sale of a stake in the business to Johnson & Johnson last month.Tysabri, which accounts for two-thirds of group turnover, saw sales jump 19 per...
- External links 2009-10-21
- Swine flu vaccine and strong pipeline give Novartis a shot in the arm
- Novartis yesterday said it expected to sell about $600m worth of its new H1N1 pandemic swine flu vaccine in the fourth quarter, significantly more than the Swiss pharmaceuticals group had earlier forecast.The increase came on top of guidance that the group expected to sell more of its core pharmaceuticals...
- External links 2009-10-22
- NHS offers hospital to private bidders
- An NHS district general hospital, complete with accident and emergency and maternity services, is being offered up for take-over by the private secto r for the first time, alongside bids from other NHS organisations.But the conditions being attached to the seven-year franchise to run the 369-bed Hinchingbrooke Hospital in...
- News items 2009-10-29
- << Previous
- page 1 of 2
- Next >>
Content Types
Refining Tags
- General News (25 results)
- Financial Times (25 results)
- Company News (15 results)
- Healthcare (11 results)
- Patient (7 results)
- Vertical Industries (6 results)
- Human Resources (6 results)
- Health Care (6 results)
- Marketing (5 results)
- Government News (5 results)
- Benefits (5 results)
- Sales (3 results)
- Vaccine (3 results)
- H1N1 Flu (3 results)
- Contracts & New Orders (3 results)
- Hospital (3 results)
- Finance (3 results)
- Sales Strategy (3 results)
- Mergers & Acquisitions (3 results)
- Sales Force Management (3 results)
- New Products & Services (3 results)
